News Survey: Pharma bullish on digital innovation, but failing on... When it comes to enthusiasm about digital innovation, pharma seems to be more adept at talking the talk than walking the walk, as it were.
News Another LAG-3 setback as Regeneron drug fails phase 3 trial Regeneron's LAG-3 inhibitor fianlimab has missed the mark in a highly anticipated melanoma trial, hitting its share price.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.